News

MacKenzie Realty Capital's $4.8 Million Offering Explained

MacKenzie Realty Capital's $4.8 Million Offering Explained

MacKenzie Realty Capital Engages in a Major Fundraising Endeavor

MacKenzie Realty Capital, Inc. (NASDAQ: MKZR), an innovative Real Estate Investment Trust (REIT), has taken a significant step forward by announcing its recent securities purchase agreement with a prominent institutional investor. This agreement involves the purchase of 2,826,299 shares of common stock, which can also be substituted with pre-funded warrants. This strategic move is part of a registered direct offering aimed at raising essential funds for the company's future developments and growth.

Details of the Offering

Understanding the Financial Aspects

The registered direct offering includes an enticing combination of purchasing stock shares and warrants for an effective offering price of $1.71 each. Alongside this, MacKenzie Realty Capital is also set to unveil unregistered Series A and Series B common warrants. These will allow investors to purchase an additional 1,413,149 shares and 2,826,299 shares of common stock, respectively. Such opportunities present beneficial buy-in options for those wishing to tap into the company's evolving profitability.

Expected Use of Proceeds

Gone are the days of uncertainty about how capital will be efficiently utilized. MacKenzie has a solid plan in place. The expected gross proceeds of approximately $4.8 million will be strategically channeled towards various capital expenditures. This includes acquiring more properties, paying down debt through strategic principal payments, and funding operational expenses among others. This calculated approach demonstrates MacKenzie’s commitment to enhancing its asset portfolio while ensuring ongoing operational efficiency.

The Role of Maxim Group LLC

To facilitate this significant offering, the company has engaged Maxim Group LLC as its sole placement agent. This partnership underscores MacKenzie’s strategy of employing seasoned professionals to guide their financial endeavors and successfully connect with potential investors.

Warrants and Their Relevance

A Look Into the Warrants Issuance

The offering will also see the issuance of warrants that each bear an exercise price of $1.71 per share. Importantly, both Series A and Series B common warrants will have different expiration timelines, signaling MacKenzie’s flexible approach to financial instruments. The Series A common warrants will become exercisable six months post-issuance and will carry an 18-month expiry, whereas the Series B warrants will offer more extended access with a five-year timeframe.

Future Prospects for Investors

The opportunity at hand serves to showcase the company's growth potential, positioning itself favorably in the competitive market of real estate investments. With well-defined plans for asset expansion and operational sustainability, existing and prospective investors can look forward to potentially rewarding outcomes.

About MacKenzie Realty Capital

Founded in 2013, MacKenzie Realty Capital aims to invest primarily in real estate properties, emphasizing multifamily units and boutique class A office spaces. The company is committed to maintaining a balanced portfolio, thereby ensuring it meets both investor interests and market demands. Notably, MacKenzie has consistently rewarded its stakeholders through regular dividend payments since inception, highlighting its financial reliability.

To explore further, interested individuals can connect with MacKenzie’s dedicated team at (800) 854-8357. The company encourages potential investors to browse its informative website for more details.

Frequently Asked Questions

What is the significance of the recent $4.8 million offering?

The offering is crucial for funding future property acquisitions and ensuring operational progress, contributing to the overall growth of MacKenzie Realty Capital.

Who is acting as the placement agent for this offering?

Maxim Group LLC has been appointed as the sole placement agent, lending their expertise to facilitate the fundraising process.

What types of warrants are being issued?

The offering includes both Series A and Series B common warrants, allowing investors various options for share purchase over differing timelines.

How does MacKenzie Realty Capital intend to use the proceeds?

The proceeds will fund acquisitions, debt reductions, operational expenses, and other corporate activities to enhance the company’s portfolio.

When is the offering expected to close?

The closing of the offering is anticipated to occur shortly, contingent upon meeting customary closing conditions, likely around early March 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 7

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading

Top 5 Most Recently Viewed Articles

Impending Price Increases on Medications in the U.S. Market

Updated Category News Views 263

Upcoming Price Increases on Medications in the U.S. By Michael Erman Drugmakers are set to increase the prices of over 250 branded medications, including well-known treatments like Pfizer's COVID-19 drug Paxlovid and Bristol Myers Squibb's cancer therapies. According to an analysis from a healthcare research firm, these increases will take effect on January 1, 2025....

Continue Reading
The Joint Commission Welcomes New Digital Leadership to Advance Healthcare

Updated Category News Views 152

The Joint Commission Appoints William Walders as CDIO The Joint Commission recently unveiled an exciting new chapter in its leadership with the appointment of William Walders as vice president and chief digital and information officer (CDIO). This strategic decision marks a significant shift towards amplifying the organization's digital transformation efforts. Walders'...

Continue Reading
Understanding Market Sentiment for Green Brick Partners

Updated Category News Views 105

Market Overview for Green Brick Partners Green Brick Partners (NYSE: GRBK) is experiencing a notable uptick in its short interest, which has risen by 7.98% since the last report. Currently, there are approximately 1.24 million shares sold short, representing about 4.06% of the total shares available for trading. With the current trading volume, analysts estimate that it...

Continue Reading
Earnings Forecasts for Major Companies on October 22, 2025

Updated Category News Views 600

Upcoming Earnings Reports Many prominent companies are slated to disclose their quarterly earnings on October 22, 2025. Investors and analysts alike are keenly awaiting these reports to gauge the companies' performances and future outlooks. Before The Market Opens • Barclays (NYSE: BCS) is expected to announce earnings of $0.54 per share with projected revenue around...

Continue Reading
First Atlantic Nickel Amplifies Drilling Efforts at Pipestone XL

Updated Category News Views 176

First Atlantic Nickel Amplifies Drilling Efforts First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) is making significant strides in its mining efforts. The Company has announced the addition of four new drill holes (AN-25-11 to AN-25-14) to its Phase 2X drilling program, particularly within the RPM Zone of the Pipestone XL Nickel Alloy Project. This...

Continue Reading